NYSE: RYANRyan Specialty Holdings Inc Stock
$50.68-0.19 (-0.37%)
Updated Oct 30, 2025
Ryan Specialty Holdings shares are... find out Why RYAN Price Moved with a free WallStreetZen account
Why Price MovedRYAN Price
$50.68
Fair Value Price
N/A
Market Cap
$13.36B
52 Week Low
$50.08
52 Week High
$77.16
P/E
112.62x
P/B
21.91x
P/S
3.06x
PEG
1.25x
Dividend Yield
0.71%
Revenue
$2.81B
Earnings
$55.68M
Gross Margin
100%
Operating Margin
12.53%
Profit Margin
2%
Debt to Equity
15.48
Operating Cash Flow
$571M
Beta
0.66
Next Earnings
Nov 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A
RYAN Overview
Ryan Specialty Group Holdings Incorporated provides specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and managing underwriter. Ryan Specialty was founded in 2010 and is headquartered in Chicago, IL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine RYAN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Insurance
Industry Rating
C
RYAN
Ranked#13 of 20
Ranked#13 of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $61.67 | A | |
| $212.43 | B | |
| $37.18 | C |
Be the first to know about important RYAN news, forecast changes, insider trades & much more!
RYAN News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RYAN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RYAN ($50.68) is trading above its intrinsic value of $17.95, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RYAN is poor value based on its earnings relative to its share price (112.62x), compared to the US market average (40.85x)
P/E vs Market Valuation
RYAN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more RYAN due diligence checks available for Premium users.
Valuation
RYAN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
112.62x
Industry
17.16x
Market
40.85x
RYAN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RYAN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
RYAN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
21.91x
Industry
1.56x
RYAN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
RYAN price to earnings growth (PEG)
For valuing profitable companies with growth potential
RYAN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
RYAN's financial health
Profit margin
Revenue
$855.2M
Net Income
$52.0M
Profit Margin
6.1%
RYAN's Earnings (EBIT) of $352.42M... subscribe to Premium to read more.
Interest Coverage Financials
RYAN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$10.6B
Liabilities
$9.4B
Debt to equity
15.48
RYAN's short-term assets ($5.27B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RYAN's short-term assets ($5.27B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RYAN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$353.6M
Investing
-$45.9M
Financing
-$102.5M
RYAN's operating cash flow ($571.34M)... subscribe to Premium to read more.
Debt Coverage Financials
RYAN vs Specialty Insurance Stocks
Ryan Specialty Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.